Recommendations for the Management of Herpes Zoster
The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2007-01, Vol.44 (Supplement-1), p.S1-S26 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S26 |
|---|---|
| container_issue | Supplement-1 |
| container_start_page | S1 |
| container_title | Clinical infectious diseases |
| container_volume | 44 |
| creator | Dworkin, Robert H. Johnson, Robert W. Breuer, Judith Gnann, John W. Levin, Myron J. Backonja, Miroslav Betts, Robert F. Gershon, Anne A. Haanpää, Maija L. McKendrick, Michael W. Nurmikko, Turo J. Oaklander, Anne Louise Oxman, Michael N. Langston, Deborah Pavan Petersen, Karin L. Rowbotham, Michael C. Schmader, Kenneth E. Stacey, Brett R. Tyring, Stephen K. Wijck, Albert J. M. van Wallace, Mark S. Wassilew, Sawko W. Whitley, Richard J. |
| description | The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ. |
| doi_str_mv | 10.1086/510206 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68357671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4485224</jstor_id><sourcerecordid>4485224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-c0dc119d16029bcdaefad45a93b270af38fbd246d9a3123e551cf7a67f5025e93</originalsourceid><addsrcrecordid>eNpFkE9LwzAYh4MoTqd-ApFe9FbN_6RHN9QJE8WpyC4hTRPtXJuZdKDf3krLdnpfeB5-hweAEwQvEZT8iiGIId8BB4gRkXKWod32h0ymVBI5AIcxLiBESEK2DwZIIEokZQeAPFvjq8rWhW5KX8fE-ZA0nzZ50LX-sC1oEu-SiQ0rG5O5j40NR2DP6WW0x_0dgtfbm5fxJJ0-3t2Pr6epoZg0qYGFQSgrEIc4y02hrdMFZTojORZQOyJdXmDKi0wThIllDBknNBeOQcxsRobgottdBf-9trFRVRmNXS51bf06Ki4JE1ygrWiCjzFYp1ahrHT4VQiq_zyqy9OKZ_3iOq9ssdX6Hq1w3gs6Gr10QdemjFsv4xnBULTeaectYuPDhlMqGca0xWmHy7bXzwbr8KW4IIKpyftcPY3eRjNB5mpG_gCgSINQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68357671</pqid></control><display><type>article</type><title>Recommendations for the Management of Herpes Zoster</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Dworkin, Robert H. ; Johnson, Robert W. ; Breuer, Judith ; Gnann, John W. ; Levin, Myron J. ; Backonja, Miroslav ; Betts, Robert F. ; Gershon, Anne A. ; Haanpää, Maija L. ; McKendrick, Michael W. ; Nurmikko, Turo J. ; Oaklander, Anne Louise ; Oxman, Michael N. ; Langston, Deborah Pavan ; Petersen, Karin L. ; Rowbotham, Michael C. ; Schmader, Kenneth E. ; Stacey, Brett R. ; Tyring, Stephen K. ; Wijck, Albert J. M. van ; Wallace, Mark S. ; Wassilew, Sawko W. ; Whitley, Richard J.</creator><creatorcontrib>Dworkin, Robert H. ; Johnson, Robert W. ; Breuer, Judith ; Gnann, John W. ; Levin, Myron J. ; Backonja, Miroslav ; Betts, Robert F. ; Gershon, Anne A. ; Haanpää, Maija L. ; McKendrick, Michael W. ; Nurmikko, Turo J. ; Oaklander, Anne Louise ; Oxman, Michael N. ; Langston, Deborah Pavan ; Petersen, Karin L. ; Rowbotham, Michael C. ; Schmader, Kenneth E. ; Stacey, Brett R. ; Tyring, Stephen K. ; Wijck, Albert J. M. van ; Wallace, Mark S. ; Wassilew, Sawko W. ; Whitley, Richard J.</creatorcontrib><description>The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/510206</identifier><identifier>PMID: 17143845</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>2-Aminopurine - analogs & derivatives ; 2-Aminopurine - therapeutic use ; Acyclovir - analogs & derivatives ; Acyclovir - therapeutic use ; Analgesics - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - therapeutic use ; Antivirals ; Biological and medical sciences ; Bromodeoxyuridine - analogs & derivatives ; Bromodeoxyuridine - therapeutic use ; Chickenpox ; Exanthema ; Herpes zoster ; Herpes Zoster - complications ; Herpes Zoster - drug therapy ; Herpes Zoster - epidemiology ; Herpes Zoster - physiopathology ; Herpesvirus 3, Human - pathogenicity ; Human herpesvirus 3 ; Human viral diseases ; Humans ; Immunocompetence ; Immunocompromised Host ; Infections ; Infectious diseases ; Medical sciences ; Pain ; Pharmacology. Drug treatments ; Postherpetic neuralgia ; Valine - analogs & derivatives ; Valine - therapeutic use ; Varicella zoster encephalitis ; Viral diseases ; Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye ; Viruses</subject><ispartof>Clinical infectious diseases, 2007-01, Vol.44 (Supplement-1), p.S1-S26</ispartof><rights>Copyright 2006 The Infectious Diseases Society of America</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-c0dc119d16029bcdaefad45a93b270af38fbd246d9a3123e551cf7a67f5025e93</citedby><cites>FETCH-LOGICAL-c423t-c0dc119d16029bcdaefad45a93b270af38fbd246d9a3123e551cf7a67f5025e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4485224$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4485224$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,777,781,800,4010,27904,27905,27906,57998,58231</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19693207$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17143845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dworkin, Robert H.</creatorcontrib><creatorcontrib>Johnson, Robert W.</creatorcontrib><creatorcontrib>Breuer, Judith</creatorcontrib><creatorcontrib>Gnann, John W.</creatorcontrib><creatorcontrib>Levin, Myron J.</creatorcontrib><creatorcontrib>Backonja, Miroslav</creatorcontrib><creatorcontrib>Betts, Robert F.</creatorcontrib><creatorcontrib>Gershon, Anne A.</creatorcontrib><creatorcontrib>Haanpää, Maija L.</creatorcontrib><creatorcontrib>McKendrick, Michael W.</creatorcontrib><creatorcontrib>Nurmikko, Turo J.</creatorcontrib><creatorcontrib>Oaklander, Anne Louise</creatorcontrib><creatorcontrib>Oxman, Michael N.</creatorcontrib><creatorcontrib>Langston, Deborah Pavan</creatorcontrib><creatorcontrib>Petersen, Karin L.</creatorcontrib><creatorcontrib>Rowbotham, Michael C.</creatorcontrib><creatorcontrib>Schmader, Kenneth E.</creatorcontrib><creatorcontrib>Stacey, Brett R.</creatorcontrib><creatorcontrib>Tyring, Stephen K.</creatorcontrib><creatorcontrib>Wijck, Albert J. M. van</creatorcontrib><creatorcontrib>Wallace, Mark S.</creatorcontrib><creatorcontrib>Wassilew, Sawko W.</creatorcontrib><creatorcontrib>Whitley, Richard J.</creatorcontrib><title>Recommendations for the Management of Herpes Zoster</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.</description><subject>2-Aminopurine - analogs & derivatives</subject><subject>2-Aminopurine - therapeutic use</subject><subject>Acyclovir - analogs & derivatives</subject><subject>Acyclovir - therapeutic use</subject><subject>Analgesics - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Antivirals</subject><subject>Biological and medical sciences</subject><subject>Bromodeoxyuridine - analogs & derivatives</subject><subject>Bromodeoxyuridine - therapeutic use</subject><subject>Chickenpox</subject><subject>Exanthema</subject><subject>Herpes zoster</subject><subject>Herpes Zoster - complications</subject><subject>Herpes Zoster - drug therapy</subject><subject>Herpes Zoster - epidemiology</subject><subject>Herpes Zoster - physiopathology</subject><subject>Herpesvirus 3, Human - pathogenicity</subject><subject>Human herpesvirus 3</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunocompetence</subject><subject>Immunocompromised Host</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pain</subject><subject>Pharmacology. Drug treatments</subject><subject>Postherpetic neuralgia</subject><subject>Valine - analogs & derivatives</subject><subject>Valine - therapeutic use</subject><subject>Varicella zoster encephalitis</subject><subject>Viral diseases</subject><subject>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</subject><subject>Viruses</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE9LwzAYh4MoTqd-ApFe9FbN_6RHN9QJE8WpyC4hTRPtXJuZdKDf3krLdnpfeB5-hweAEwQvEZT8iiGIId8BB4gRkXKWod32h0ymVBI5AIcxLiBESEK2DwZIIEokZQeAPFvjq8rWhW5KX8fE-ZA0nzZ50LX-sC1oEu-SiQ0rG5O5j40NR2DP6WW0x_0dgtfbm5fxJJ0-3t2Pr6epoZg0qYGFQSgrEIc4y02hrdMFZTojORZQOyJdXmDKi0wThIllDBknNBeOQcxsRobgottdBf-9trFRVRmNXS51bf06Ki4JE1ygrWiCjzFYp1ahrHT4VQiq_zyqy9OKZ_3iOq9ssdX6Hq1w3gs6Gr10QdemjFsv4xnBULTeaectYuPDhlMqGca0xWmHy7bXzwbr8KW4IIKpyftcPY3eRjNB5mpG_gCgSINQ</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Dworkin, Robert H.</creator><creator>Johnson, Robert W.</creator><creator>Breuer, Judith</creator><creator>Gnann, John W.</creator><creator>Levin, Myron J.</creator><creator>Backonja, Miroslav</creator><creator>Betts, Robert F.</creator><creator>Gershon, Anne A.</creator><creator>Haanpää, Maija L.</creator><creator>McKendrick, Michael W.</creator><creator>Nurmikko, Turo J.</creator><creator>Oaklander, Anne Louise</creator><creator>Oxman, Michael N.</creator><creator>Langston, Deborah Pavan</creator><creator>Petersen, Karin L.</creator><creator>Rowbotham, Michael C.</creator><creator>Schmader, Kenneth E.</creator><creator>Stacey, Brett R.</creator><creator>Tyring, Stephen K.</creator><creator>Wijck, Albert J. M. van</creator><creator>Wallace, Mark S.</creator><creator>Wassilew, Sawko W.</creator><creator>Whitley, Richard J.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Recommendations for the Management of Herpes Zoster</title><author>Dworkin, Robert H. ; Johnson, Robert W. ; Breuer, Judith ; Gnann, John W. ; Levin, Myron J. ; Backonja, Miroslav ; Betts, Robert F. ; Gershon, Anne A. ; Haanpää, Maija L. ; McKendrick, Michael W. ; Nurmikko, Turo J. ; Oaklander, Anne Louise ; Oxman, Michael N. ; Langston, Deborah Pavan ; Petersen, Karin L. ; Rowbotham, Michael C. ; Schmader, Kenneth E. ; Stacey, Brett R. ; Tyring, Stephen K. ; Wijck, Albert J. M. van ; Wallace, Mark S. ; Wassilew, Sawko W. ; Whitley, Richard J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-c0dc119d16029bcdaefad45a93b270af38fbd246d9a3123e551cf7a67f5025e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>2-Aminopurine - analogs & derivatives</topic><topic>2-Aminopurine - therapeutic use</topic><topic>Acyclovir - analogs & derivatives</topic><topic>Acyclovir - therapeutic use</topic><topic>Analgesics - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Antivirals</topic><topic>Biological and medical sciences</topic><topic>Bromodeoxyuridine - analogs & derivatives</topic><topic>Bromodeoxyuridine - therapeutic use</topic><topic>Chickenpox</topic><topic>Exanthema</topic><topic>Herpes zoster</topic><topic>Herpes Zoster - complications</topic><topic>Herpes Zoster - drug therapy</topic><topic>Herpes Zoster - epidemiology</topic><topic>Herpes Zoster - physiopathology</topic><topic>Herpesvirus 3, Human - pathogenicity</topic><topic>Human herpesvirus 3</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunocompetence</topic><topic>Immunocompromised Host</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pain</topic><topic>Pharmacology. Drug treatments</topic><topic>Postherpetic neuralgia</topic><topic>Valine - analogs & derivatives</topic><topic>Valine - therapeutic use</topic><topic>Varicella zoster encephalitis</topic><topic>Viral diseases</topic><topic>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dworkin, Robert H.</creatorcontrib><creatorcontrib>Johnson, Robert W.</creatorcontrib><creatorcontrib>Breuer, Judith</creatorcontrib><creatorcontrib>Gnann, John W.</creatorcontrib><creatorcontrib>Levin, Myron J.</creatorcontrib><creatorcontrib>Backonja, Miroslav</creatorcontrib><creatorcontrib>Betts, Robert F.</creatorcontrib><creatorcontrib>Gershon, Anne A.</creatorcontrib><creatorcontrib>Haanpää, Maija L.</creatorcontrib><creatorcontrib>McKendrick, Michael W.</creatorcontrib><creatorcontrib>Nurmikko, Turo J.</creatorcontrib><creatorcontrib>Oaklander, Anne Louise</creatorcontrib><creatorcontrib>Oxman, Michael N.</creatorcontrib><creatorcontrib>Langston, Deborah Pavan</creatorcontrib><creatorcontrib>Petersen, Karin L.</creatorcontrib><creatorcontrib>Rowbotham, Michael C.</creatorcontrib><creatorcontrib>Schmader, Kenneth E.</creatorcontrib><creatorcontrib>Stacey, Brett R.</creatorcontrib><creatorcontrib>Tyring, Stephen K.</creatorcontrib><creatorcontrib>Wijck, Albert J. M. van</creatorcontrib><creatorcontrib>Wallace, Mark S.</creatorcontrib><creatorcontrib>Wassilew, Sawko W.</creatorcontrib><creatorcontrib>Whitley, Richard J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dworkin, Robert H.</au><au>Johnson, Robert W.</au><au>Breuer, Judith</au><au>Gnann, John W.</au><au>Levin, Myron J.</au><au>Backonja, Miroslav</au><au>Betts, Robert F.</au><au>Gershon, Anne A.</au><au>Haanpää, Maija L.</au><au>McKendrick, Michael W.</au><au>Nurmikko, Turo J.</au><au>Oaklander, Anne Louise</au><au>Oxman, Michael N.</au><au>Langston, Deborah Pavan</au><au>Petersen, Karin L.</au><au>Rowbotham, Michael C.</au><au>Schmader, Kenneth E.</au><au>Stacey, Brett R.</au><au>Tyring, Stephen K.</au><au>Wijck, Albert J. M. van</au><au>Wallace, Mark S.</au><au>Wassilew, Sawko W.</au><au>Whitley, Richard J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations for the Management of Herpes Zoster</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>44</volume><issue>Supplement-1</issue><spage>S1</spage><epage>S26</epage><pages>S1-S26</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>The objective of this article is to provide evidence-based recommendations for the management of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects, impact on quality of life, and costs of treatment. Systematic literature reviews, published randomized clinical trials, existing guidelines, and the authors' clinical and research experience relevant to the management of patients with HZ were reviewed at a consensus meeting. The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacyclovir as first-line antiviral therapy for the treatment of patients with HZ. Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>17143845</pmid><doi>10.1086/510206</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2007-01, Vol.44 (Supplement-1), p.S1-S26 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68357671 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current) |
| subjects | 2-Aminopurine - analogs & derivatives 2-Aminopurine - therapeutic use Acyclovir - analogs & derivatives Acyclovir - therapeutic use Analgesics - therapeutic use Anti-Inflammatory Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - therapeutic use Antivirals Biological and medical sciences Bromodeoxyuridine - analogs & derivatives Bromodeoxyuridine - therapeutic use Chickenpox Exanthema Herpes zoster Herpes Zoster - complications Herpes Zoster - drug therapy Herpes Zoster - epidemiology Herpes Zoster - physiopathology Herpesvirus 3, Human - pathogenicity Human herpesvirus 3 Human viral diseases Humans Immunocompetence Immunocompromised Host Infections Infectious diseases Medical sciences Pain Pharmacology. Drug treatments Postherpetic neuralgia Valine - analogs & derivatives Valine - therapeutic use Varicella zoster encephalitis Viral diseases Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye Viruses |
| title | Recommendations for the Management of Herpes Zoster |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20for%20the%20Management%20of%20Herpes%20Zoster&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Dworkin,%20Robert%20H.&rft.date=2007-01-01&rft.volume=44&rft.issue=Supplement-1&rft.spage=S1&rft.epage=S26&rft.pages=S1-S26&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/510206&rft_dat=%3Cjstor_proqu%3E4485224%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68357671&rft_id=info:pmid/17143845&rft_jstor_id=4485224&rfr_iscdi=true |